id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-V-3378-0003,FDA,FDA-2022-V-3378,Variance Approval from FDA CDRH to Judd Lacson,Other,Approval for Variance (VRA),2023-01-23T05:00:00Z,2023,1,2023-01-23T05:00:00Z,,2023-01-23T16:55:31Z,,0,0,09000064856027b3
FDA-2022-V-3378-0002,FDA,FDA-2022-V-3378,Acknowledgment Letter from FDA DMS to Judd Lacson,Other,Acknowledgement Letter/Receipt,2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T14:31:31Z,,0,0,090000648555c329
FDA-2022-V-3378-0001,FDA,FDA-2022-V-3378,Variance Application from Judd Lacson,Other,Application for Variance (VAR),2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T14:28:05Z,,0,0,090000648555b41a